Among these, 9 immune cell types, such as CD19 on IgD( +) CD24(−), were identified as risk factors for glioma (Supplementary Fig. 1), while 10 immune cell types, such as CD11c on monocyte, were considered protective factors for glioma (Supplementary Fig. 2). The gene discussed is CD19; the disease is central nervous system cancer.